Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc AGNPF

Primary Symbol: C.AGN

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

Add To Watchlist

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc > IPF's orphan disease indication beneficial to AGN

View:

Post by waves1 on Jul 26, 2022 3:53pm

IPF's orphan disease indication beneficial to AGN

More on Algernon's ($AGN.c $AGNPF) Phase 2a study of Ifenprodil:
https://themarketherald.ca/crossing-the-finish-line-algernon-cseagn-reaches-endpoint-in-phase-2a-study-of-ifenprodil-2022-07-22/

As IPF seriously compromises the quality of life of those with it, with no full cure and the lack of effective treatment, AGN would be entering a market with essentially no competition, plus, any approved drugs are provided a 7-10 year market exclusivity as IPF has been classified as an "orphan disease indication"